Deletion of the A35 Gene from Modified Vaccinia Virus Ankara Increases Immunogenicity and Isotype Switching

di Rehm, Kristina E., Roper, Rachel L.
Pubblicazione 2011

Physical activity levels and perceived benefits and barriers to physical activity in HIV-infected women living in the Deep South of the United States

di Rehm, Kristina E., Konkle-Parker, Deborah
Pubblicato in AIDS Care (2016)

SARS vaccines: where are we?

di Roper, Rachel L, Rehm, Kristina E
Pubblicato in Expert Rev Vaccines (2014)

Stress and Allergic Diseases

di Dave, Ninabahen D., Xiang, Lianbin, Rehm, Kristina E., Marshall, Gailen D.
Pubblicazione 2011

Vaccinia Virus A35R Inhibits MHC Class II Antigen Presentation

di Rehm, Kristina E., Connor, Ramsey F., Jones, Gwendolyn J.B., Yimbu, Kenneth, Roper, Rachel L.
Pubblicazione 2009

The Poxvirus A35 Protein Is an Immunoregulator

di Rehm, Kristina E., Jones, Gwendolyn J. B., Tripp, Alice A., Metcalf, Mark W., Roper, Rachel L.
Pubblicazione 2010

Vaccinia virus decreases major histocompatibility complex (MHC) class II antigen presentation, T-cell priming, and peptide association with MHC class II

di Rehm, Kristina E, Connor, Ramsey F, Jones, Gwendolyn J B, Yimbu, Kenneth, Mannie, Mark D, Roper, Rachel L
Pubblicazione 2009